Tag: Pharmaceutical industry news
Pharmalittle: Lilly Drug Shortage Ends, Novo Obesity Trial Disappoints & More – Latest Updates
Novo Nordisk’s Obesity Trial Disappoints
Novo Nordisk, a key player in the pharmaceutical industry, recently faced a setback with their next-generation obesity candidate, CagriSema. The pivotal study results showed that the treatment helped patients lose...
Congress Cracks Down on PBMs, Sanofi Sues HHS: Pharmalittle Update
Congressional Crackdown on PBMs
After two years of intense negotiations, Congress is on the brink of finalizing a deal that will rein in pharmacy benefit managers (PBMs). According to a report by STAT, lawmakers have...
Medicare Negotiating Obesity-Drug Prices, Novartis 340B Lawsuit, Pharma News
**Medicare to Negotiate Prices for Obesity and Diabetes Drugs, Novartis Sues Over 340B Program**In a groundbreaking move, Medicare officials have announced plans to engage in price negotiations for two major drugs, Ozempic and Wegovy,...
Neumora’s Antidepressant Phase 3 Trial Results: What Went Wrong?
Neumora's Antidepressant Phase 3 Trial Results: A Deeper Dive into the Disappointing OutcomeIn a recent groundbreaking development, startup Neumora Therapeutics faced a setback with its latest depression treatment, navacaprant, as it failed to deliver...
